跳至主要内容
临床试验/CTRI/2012/08/002902
CTRI/2012/08/002902招募中2 期

“FURTHER STUDY ON SWETA PRADAR(VAGINAL DISCHARGE) ANDIT’S MANAGEMENT WITH NIMBADI YOGA .â€

IPGT and RA1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年6月9日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
drug standardization

研究概览

简要总结

Swetapradarawhich occurs due to genital tract infection, has been linked to the occurrenceof tubal factor infertility and ectopic pregnancy.

 Every woman may experience white dischargein their life, but it is not always necessary to take treatment. Only wheneverthe woman suffer from some certain pathological conditions the effectivetreatment is very essential otherwise it leads to certain complications.

     In modern system of medicineantiprotozoals, antifungal and antibiotic is prescribed as per cause. Due toantiprotozoals many women experience gastrointestinal upset, headache,glossitis, stomatitis, dizziness, ataxia and very rarely convulsions. Due toantifungal gastrointestinal upset like nausea, vomiting, abdominal pain anddiarrhoea, skin rash, headache, dizziness, depression, paraesthesia andvertigo. Due to antibiotic nausea, vomiting, epigastric pain, skin rash, headache, dizziness, and cholestatic jaundice. Mostly drugs are used for localapplication, due to this local irritation and burning sensation is common and rarelyhypersensitivity reaction occurs.

       So it is great scope of research to find out safe, potent, costeffective remedy from Ayurveda for the management of Swetapradar. From theprevious work, it is well proved that this health hazard can be well managedwith certain Ayurvedic therapies.

 It as been proved by the previous work that Nimbadi Yoga iseffective compound in the management of Swetapradara and to establish this itshould compare with modern medicine. So the further study entitled.

 "FURTHER STUDY ON SWETAPRADAR(VAGINAL DISCHARGE) AND ITSMANAGEMENT WITH NIMBADI YOGA."

研究设计

研究类型
Interventional
分配方式
Stratified randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Married woman.
  • The patient having clinical sign & symptoms of swetapradar.
  • The patient having positive causative organism by wet smear test.

排除标准

  • Unmarried woman Pregnant woman Patient suffering from Tuberculosis, Sexually Transmitted Disease like VDRL, HIV, gonorrhea, Genital malignancy and Congenital and any other pathologies of reproductive tract.

结局指标

主要结局

drug standardization

时间窗: 15 months

次要结局

  • public interest(16 months)

研究者

发起方
IPGT and RA
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验